Neurocrine Biosciences Appoints Dr. Sanjay Keswani as Chief Medical Officer

Accomplished physician-scientist brings more than 20 years of industry leadership experience and broad R&D expertise in multiple therapeutic areas SAN DIEGO , April 4, 2025 /PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX ) today announced the appointment of Sanjay Keswani , M.D.

, to the company's executive management team as Chief Medical Officer (CMO) effective June 2, 2025 . Dr. Keswani, an accomplished physician-scientist who has more than 20 years of pharmaceutical industry experience with broad R&D expertise in multiple therapeutic areas, will lead the clinical development and medical affairs activities at Neurocrine.



Dr. Keswani succeeds Eiry W. Roberts, M.

D., who has served as CMO for the past seven years and who will remain with Neurocrine in a strategic advisory role..